Dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel disease

Expert Review of Gastroenterology and Hepatology

Volumn 9, Issue 6, 2015, Pages 807-820

  Sodagari, Hamid Reza ^a   Farzaei, Mohammad Hosein ^b,c   Bahramsoltani, Roodabeh ^c,d   Abdolghaffari, Amir Hossein ^c,e   Mahmoudi, Maryam ^f   Rezaei, Nima ^c,g,h  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Institute of Medicinal Plants   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Anthocyanin; dietary supplementation; inflammation; inflammatory bowel disease; inflammatory cytokines; Natural products

Indexed keywords

ANTHOCYANIN; AZATHIOPRINE; BERBERIS VULGARIS EXTRACT; BLUEBERRY EXTRACT; CYCLOSPORIN; GLUCOCORTICOID; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; NATURAL PRODUCT; PLANT EXTRACT; SALAZOSULFAPYRIDINE; STRAWBERRY EXTRACT; TACROLIMUS; TIOGUANINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANTIINFLAMMATORY ACTIVITY; ARTERY DISEASE; BERBERIS VULGARIS; BLACK RASPBERRY; BLUEBERRY; CAMELLIA; CARDIOTOXICITY; CELL PROTECTION; COLITIS; CRANBERRY; CRANBERRY JUICE; CROHN DISEASE; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DIARRHEA; DIET SUPPLEMENTATION; DIETARY FIBER; FRUITARIAN DIET; GINGIVA HYPERPLASIA; GRAPE; GRAPE JUICE; HEMATOLOGIC DISEASE; HUMAN; HYPERTENSION; INCIDENCE; INFLAMMATORY BOWEL DISEASE; LEUKOPENIA; LIVER TOXICITY; NAUSEA; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PANCREATITIS; PATHOPHYSIOLOGY; PHASEOLUS VULGARIS; PREVALENCE; RASPBERRY; REVIEW; STRAWBERRY; SUNROUGE; ULCERATIVE COLITIS; VACCINIUM MYRTILLUS; VOMITING; ADVERSE EFFECTS; ALTERNATIVE MEDICINE; DIET; DIET THERAPY; DIETARY SUPPLEMENT; FABACEAE; FRUIT; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; TREATMENT OUTCOME;

ANTHOCYANINS; COMPLEMENTARY THERAPIES; DIET; DIETARY SUPPLEMENTS; FABACEAE; FRUIT; HUMANS; INFLAMMATORY BOWEL DISEASES; TREATMENT OUTCOME;

EID: 84929924320     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/17474124.2015.1002086     Document Type: Review

References (166)

1. Debnath T, Hasnat MA, Pervin M, et al. Chaga mushroom (Inonotus obliquus) grown on germinated brown rice suppresses inflammation associated with colitis in mice. Food Sci Biotechnol 2012;21:1235-41
2. Bamford KB. Chronic gastrointestinal inflammation. FEMS Immunol Med Microbiol 1999;24:161-8
3. Pithadia A, Jain S. Treatment of inflammatory bowel disease (IBD). Pharmacol Rep 2011;63:629-42
4. Butterworth JR. Chemoprevention of colorectal cancer in inflammatory bowel disease. Dig Liver Dis 2009;41:338-9
5. Baumgart DC, Carding SR. Gastroenterology 1-Inflammatory bowel disease: cause and immunobiology. Lancet 2007;369:1627-40.
6. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29
7. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78
8. Baumgart DC, Sandborn WJ. Gastroenterology 2-Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;369: 1641-57.
9. Lucas A, Cobelens PM, Kavelaars A, et al. Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission. J Neuroimmunol 2007;182:195-203
10. Pache I, Rogler G, Felley C. TNF-alpha blockers in inflammatory bowel diseases: practical consensus recommendations and a user's guide. Swiss Med Wkly 2009;139: 278-87
11. Kruidenier L, Kuiper I, Lamers CB, et al. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003;201:28-36
12. Naito Y, Takagi T, Yoshikawa T. Molecular fingerprints of neutrophil dependent oxidative stress in inflammatory bowel disease. J Gastroenterol 2007;42:787-98
13. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997;82:291-5
14. Buttke TM, Sandstorm PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15(1):7-10
15. Maor I, Rainis T, Lanir A, et al. Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease. Dig Dis Sci 2008;53: 2208-14
16. Nieto N, Torres MI, Fernández MI, et al. Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig Dis Sci 2000;45:1820-7
17. Halliwell B, Gutreridge JMC. Free radicals in biology and medicine. 2nd edition. Clarendon Press; Oxford, UK: 1989
18. Michael H, Prieto JM. Diet and healthy ageing 2100: will we globalise local knowledge systems? Ageing Res Rev 2008;7: 249-74
19. Thia KT, Loftus EV, Jr Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008;103:3167-82
20. Abramson O, Durant M, Mow W, et al. Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. J Pediatr 2010;157:233-239.e1
21. Chouraki V, Savoye G, Dauchet L, et al. The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10-to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther 2011;33:1133-42
22. Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol 2006;12:6102-8
23. Cosnes J, Gower-Rousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011;140:1785-94
24. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences. Gastroenterology 2004;126:1504-17
25. Sanfod LT, Taffet MD, Kiron M, et al. Sulfasalazine. Dig Dis Sci 1983;28(9): 833-42
26. Zachariae H. Methotrexate side-effects. Br J Dermatol 1990;122(Suppl 36):127-33
27. Whisnant JK, Pelkey J. Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities. Ann Rheum Dis 1982;41(Suppl):44-7
28. Boulton-jones JR, Pritchard K, Mahmoud AA. The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy. Aliment Pharmacol Ther 2000;14(12):1561-5
29. Mihatsch MJ, Kyo M, Morozumi K, et al. The side-effects of ciclosporine-A and tacrolimus. Clin Nephrol 1998;49(6): 356-63
30. Joshi R, Kumar S, Unnikrishnan M, et al. Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity. Free Radic Res 2005;39:1163-72
31. Sutherland L, Macdonald JK. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2006(2):CD000544
32. Faubion WA, Loftus EV, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001;121:255-60
33. Cho EJ, Shin JS, Noh YS, et al. Anti-inflammatory effects of methanol extract of Patrinia scabiosaefoliain mice with ulcerative colitis. J Ethnopharmacol 2011;136:428-35
34. Jani N, Regueiro MD. Medical therapy for ulcerative colitis. Gastroenterol Clin North Am 2002;31:147-66
35. Lakatos PL, Lakatos L. Ulcerative proctitis: a review of pharmacotherapy and management. Expert Opin Pharmacother 2008;9:741-9
36. Engel MA, Neurath MF. New pathophysiological insights and modern treatment of IBD. J Gastroenterol 2010;45: 571-83
37. Moser G, Tillinger W, Sachs G, et al. Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J Psychosom Res 1996;40(5):503-9
38. Langhorst J, Anthonisen IB, Steder-Neukamm U, et al. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Inflamm Bowel Dis 2005;11(3):287-95
39. Debnath T, Kim DH, Lim BO. Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease. Molecules 2013;18:7253-70
40. Marrugat J, Covas MI, Fito M, et al. SOLOS Investigators. Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation- A randomized controlled trial. Eur J Nutr 2004;43:140-7
41. Schroeter H, Heiss C, Balzer J, et al. (-)Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci USA 2006;103:1024-9
42. Grassi D, Lippi C, Necozione S, et al. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 2005;81:611-14
43. Farzaei MH, Khanavi M, Moghaddam G, et al. Standardization of Tragopogong graminifolius DC. extracts based on phenolic compounds and antioxidant activity. J Chem 2014;2014:425965
44. Hur SJ, Kang SH, Jung HS, et al. Review of natural products actions on cytokines in inflammatory bowel disease. Nutr Res 2012;32:801-16.
45. Lekakis J, Rallidis LS, Andreadou I, et al. Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005;12:596-600
46. Ruano J, Lopez-Miranda J, Fuentes F, et al. Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J Am Coll Cardiol 2005;46:1864-8
47. Manach C, Mazur A, Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 2005;16:77-84
48. Hughes DA. Plant polyphenols: modifiers of immune function and risk of cardiovascular disease. Nutrition 2005;21: 422-3
49. Dreiseitel A, Schreier P, Oehme A, et al. Inhibition of proteasome activity by anthocyanins and anthocyanidins. Biochem Biophys Res Commun 2008;372:57-6.
50. Andersen ∅, Jordheim M. Anthocyaninsfood applications. 5th Pigments in Food congress-for quality and health. University of Helsinki; 2008. ISBN 978-952-10-4846-3
51. Kong JM, Chia LS, Goh NK, et al. Analysis and biological activities of anthocyanins. Phytochemistry 2003;64: 923-33
52. He J, Magnuson BA, Lala G, et al. Intact anthocyanins and metabolites in rat urine and plasma after 3 months of anthocyanin supplementation. Nutr Cancer 2006;54: 3-12
53. Clifford MN. Anthocyanins-nature, occurrence and dietary burden. J Sci Food Agric 2000;80:1063-72
54. Prior RL, Wu X. Anthocyanins: structural characteristics that result in unique metabolic patterns and biological activities. Free Radic Res 2006;40:1014-28
55. Jaganath IB, Crozier A. Dietary flavonoids and phenolic compounds. In: Fraga CG, editor. Plant phenolics and human health: biochemistry, nutrition, and pharmacology. John Wiley & Sons, Inc; Hoboken, NJ, USA: 2010
56. Wang LS, Stoner GD. Anthocyanins and their role in cancer prevention. Cancer Lett 2008;269:281-90
57. Del Rio D, Borges G, Crozier A. Berryflavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr 2010;104:S67-90
58. Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr 2007;37: 1244-52
59. Frankel EN, Waterhouse AL, Teissedre PL. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J Agric Food Chem 1995;43:890-4
60. Pe-rez-Jimenez J, Fezeu L, Touvier M, et al. Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr 2011;93:1-9
61. Wu X, Beecher GR, Holden JM, et al. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 2006;54:4069-75
62. Yang M, Koo SI, Song WO, et al. Food matrix affecting anthocyanin bioavailability: review. Curr Med Chem 2011;18:291-300
63. Kahle K, Kraus M, Scheppach W, et al. Studies on apple and blueberry fruit constituents: do the polyphenols reach the colon after ingestion? Mol Nutr Food Res 2006;50:418-23
64. Konczak I, Zhang W. Anthocyanins-more than nature's colours. J Biomed Biotechnol 2004;2004:239-40
65. Knox YM, Hayashi K, Suzutani T, et al. Activity of anthocyanins from fruit extract of Ribes nigrum L. against influenza A and B viruses. Acta Virol 2001;45:209-15
66. Lazzè MC, Pizzala R, Perucca P, et al. Anthocyanidins decrease endothelin-1 production and increase endothelial nitric oxide synthase in human endothelial cells. Mol Nutr Food Res 2006;50:44-51
67. Roy S, Khanna S, Alessio HM, et al. Anti angiogenic property of edible berries. Free Radic Res 2002;36:1023-31
68. Hou DX. Potential mechanisms of cancer chemoprevention by anthocyanins. Curr Mol Med 2003;3:149-59
69. Wang H, Nair MG, Strasburg GM, et al. Antioxidant and anti-inflammatory activities of anthocyanins and their aglycon, cyanidin, fromtart cherries. J Nat Prod 1999;62:294-6
70. Biasi F, Astegiano M, Maina M, et al. Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease. Curr Med Chem 2011;18:4851-65
71. Hou DX, Yanagita T, Uto T, et al. Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanism involved. Biochem Pharmacol 2005;70:417-25
72. Paturi G, Mandimika T, Butts CA, et al. Influence of dietary blueberry and broccoli on cecal microbiota activity and colon morphology in mdr1a/mice, a model of inflammatory bowel diseases. Nutrition 2012;28:324-30
73. Hakkinen SH, Torronen AR. Content of flavonols and selected phenolic acids in strawberries and Vaccinium species: influence of cultivar, cultivation site and technique. Food Res Int 2000;33:517-24
74. Versari A, Biesenbruch S, Barbanti D, et al. Effects of pectolytic enzymes on selected phenolic compounds in strawberry and raspberry juices. Food Res Int 1998;10: 811-17
75. Mazza G, Miniati E. Anthocyanins in fruits, vegetables and grains. 1st edition. CRC Press; Boca Raton, FL, USA: 1993
76. Andersen ∅M, Fossen T, Torskangerpoll K, et al. Anthocyanin from strawberry (Fragaria ananassa) with the novel aglycone, 5-carboxypyranopelargonidin. Phytochemistry 2004;65:405-10
77. Fossen T, Rayyan S, Andersen M. Dimeric anthocyanins from strawberry (Fragaria ananassa) consisting of pelargonidin 3-glucoside covalently linked to four flavan-3-ols. Phytochemistry 2004;65: 1421-8
78. Wang SY, Jiao H. Scavenging capacity of berry crops on superoxide radicals, hydrogen peroxide, hydroxyl radicals, and singlet oxygen. J Agric Food Chem 2000;48: 5677-84
79. Prior RL, Wu L, Gu TJ, et al. Whole berries versus berry anthocyanins: interactions with dietary fat levels in the C57BL/6J mouse model of obesity. J Agric Food Chem 2008;56:647-53
80. Naemura A, Mitani T, Ijiri Y, et al. Anti-thrombotic effect of strawberries. Blood Coagul Fibrinolysis 2005;16:501-9
81. Torronen R, Maatta K. Bioactive substances and health benefits of strawberries. Acta Hortic 2002;567:797-803
82. Hannum SM. Potential impact of strawberries on human health: a review of the science. Crit Rev Food Sci Nutr 2004;44:1-17
83. Felgines C, Talavera S, Gonthier MP, et al. Strawberry anthocyanins are recovered in urine as glucuro-and sulfoconjugates in humans. J Nutr 2003;133:1296-301
84. Azzini E, Vitaglione P, Intorre F, et al. Bioavailability of strawberry antioxidants in human subjects. Br J Nutr 2010;104: 1165-73
85. Mullen W, Edwards CA, Serafini M, et al. Bioavailability of pelargonidin-3-O-glucoside and its metabolites in humans following the ingestion of strawberries with and without cream. J Agric Food Chem 2008;56:713-19
86. Tanideh N, Akbari Baseri F, Jamshidzadeh A, et al. The healing effect of strawberry extract on acetic acid-induced Ulcerative colitis in rat. World Appl Sci J 2014;31:281-8
87. Gough RE. The highbush blueberry and its management. Food Products Press; New York, N.Y: 1994
88. Elks CM, Reed SD, Mariappan N, et al. A blueberry-enriched diet attenuates nephropathy in a rat model of hypertension via reduction in oxidative stress. PLoS One 2011;6:e24028
89. Sellappan S, Akoh CC, Krewer G. Phenolic compounds and antioxidant capacity of Georgia-grown blueberries and blackberries. J Agric Food Chem 2002;50:2432-8
90. Ahmet I, Spangler E, Shukitt-Hale B, et al. Blueberry-enriched diet protects rat heart from ischemic damage. PLoS One 2009;4: e5954
91. Lau FC, Bielinski DF, Joseph J. Inhibitory effects of blueberry extract on the production of inflammatory mediators in lipopolysaccharide-activated BV2 microglia. J Neurosci Res 2007;85:1010-17
92. Prior RL, Wu X, Gu L, et al. Purified berry anthocyanins but not whole berries normalize lipid parameters in mice fed an obesogenic high fat diet. Mol Nutr Food Res 2009;53:1406-18
93. Camire ME. Bilberries and blueberries as functional foods and nutraceuticals. In: Mazza G, Oomah BD, editors. Functional foods: herbs, botanicals and teas. Technomic Publishing; Lancaster: 2000. p. 289-319
94. Vendrame S, Daugherty A, Kristo AS, et al. Wild blueberry (Vaccinium angustifolium) consumption improves inflammatory status in the obese Zucker rat model of the metabolic syndrome. J Nutr Biochem 2013;24:1508-12
95. Cheng A, Yan H, Han C, et al. Polyphenols from blueberries modulate inflammation cytokines in LPS induced RAW264.7 macrophages. Int J Biol Macromol 2014;69:382-7
96. Xie C, Kang J, Ferguson ME, et al. Blueberries reduce pro-inflammatory cytokine TNF- A and IL-6 production in mouse macrophages by inhibiting NF-kB activation and the MAPK pathway. Mol Nutr Food Res 2011;55:1587-91
97. Yi W, Akoh CC, Fischer J, et al. Absorption of anthocyanins from blueberry extracts by caco-2 human intestinal cell monolayers. J Agric Food Chem 2006;54: 5651-8
98. Ribnicky DM, Roopchand DE, Oren A, et al. Effects of a high fat meal matrix and protein complexation on the bioaccessibility of blueberry anthocyanins using the TNO gastrointestinal model (TIM-1). Food Chem 2014;142:349-57
99. Wu LH, Xu AL, Dong D, et al. Protective effect of anthocyanins extract from blueberry on TNBS-induced IBD model of mice. Evid Based Complement Alternat Med 2011;2011:525462
100. Osman N, Adawi D, Ahrne S, et al. Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis. Dig Dis Sci 2008;53: 2464-73
101. Kowalczyk C, Kxzesmski P, Kura M, et al. Anthocyanins in medicine. Pol J Pharmacol 2003;55:699-702
102. Bagchi D, Sen CK, Bagchi M, et al. Antiangiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Mosc) 2004;69:75-80
103. Yildirim HK. Evaluation of colour parameters and antioxidant activities of fruit wine. Int J Food Sci Nutr 2006;57:47-63
104. Cravotto G, Boffa L, Genzini L, et al. Phytotherapeutics: an evaluation of the potential of 1000 plants. J Clin Pharm Ther 2010;35:11-48
105. Upton R. Bilberry Fruit Vaccinium myrtillus L. Standards of analysis, quality control, and therapeutics. American Herbal Pharmacopoeia and Therapeutic Compendium; Santa Cruz, CA: 2001
106. Burdulis D, Sarkinas A, Jasutienè I, et al. Comparative study of anthocyanin composition, antimicrobial and antioxidant activity in bilberry (Vaccinium myrtillus L.) and blueberry (Vaccinium corymbosum L.) fruits. Acta Pol Pharm 2009;66:399-408
107. Seeram NP. Berry fruits: compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease. J Agric Food Chem 2008;56:627-9
108. Ichiyanagi T, Shida Y, Rahman MM, et al. Bioavailability and tissue distribution of anthocyanins in bilberry (Vaccinium myrtillus L.) extract in rats. J Agric Food Chem 2006;54:6578-87
109. Sakakibara H, Ogawa T, Koyanagi A, et al. Distribution and excretion of bilberry anthocyanins in mice. J Agric Food Chem 2009;57:7681-6
110. Talavera S, Felgines C, Texier O, et al. Bioavailability of a bilberry anthocyanin extract and its impact on plasma antioxidant capacity in rats. J Sci Food Agric 2006;86: 90-7
111. Chen J, Uto T, Tanigawa S, et al. Expression profiling of genes targeted by bilberry (Vaccinium myrtillus) in macrophages through DNA array. Nutr Cancer 2008;60:43-50
112. Kim YS, Young MR, Bobe G, et al. Bioactive food components, inflammatory targets and cancer prevention. Cancer Prev Res 2009;2:200-8
113. Karlsen A, Retterstol L, Laake P, et al. Anthocyanins inhibit nuclear factor-B activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr 2007;137:1951-4
114. Jakesevic M, Xu J, Aaby K, et al. Effects of bilberry (Vaccinium myrtillus) in combination with lactic acid bacteria on intestinal oxidative stress induced by ischemia-reperfusion in mouse. J Agric Food Chem 2013;61:3468-78
115. Piberger H, Oehme A, Hofmann C, et al. Bilberries and their anthocyanins ameliorate experimental colitis. Mol Nutr Food Res 2011;55:1724-9
116. Biedermann L, Mwinyi J, Scharl M, et al. Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis-An open pilot study. J Crohn's Colitis 2013;7: 271-9
117. Mahady GB, Fong HHS, Farnsworth NR. Cranberry. In: Botanical dietary supplements: quality, safety and efficacy. Swets and Zeilinger; Lisse, Netherlands: 2001. p. 23-35
118. Mahady GB, Fong HHS, Farnsworth NR. WHO Monographs on Selected Medicinal Plants. Volume 4. WHO Publications; Geneva, Switzerland: Fructus Macrocarponii 2008. p. 132-47
119. Jepson R, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2001(2): CD001321
120. Neto CC. Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases. Mol Nutr Food Res 2007;51:652-64
121. Vinson JA, Bose P, Proch J, et al. Cranberries and cranberry products: powerful in vitro, ex vivo, and in vivo sources of antioxidants. J Agric Food Chem 2008;56:5884-91
122. Chambers BK, Camire ME. Can cranberry supplementation benefit adults with type 2 diabetes? Diabetes Care 2003;26: 2695-6
123. Huang Y, Nikolic D, Pendland S, et al. Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-kb transcriptional response in vitro. Pharm Biol 2009;47: 18-25
124. Cimolai N, Cimolai T. The cranberry and the urinary tract. Eur J Clin Microbiol Infect Dis 2007;26:767-76
125. Sun J, Hai Liu R. Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett 2006;241:124-34
126. Fuleki T, Francis FJ. Quantitative methods for anthocyanins. Purification of cranberry anthocyanins. J Food Sci 1968;33:266-9
127. Wang SY, Stretch AW. Antioxidant capacity in cranberry is influenced by cultivar and storage temperature. J Agric Food Chem 2001;49:969-74
128. Vvedenskaya IO, Vorsa N. Flavonoid composition over fruit development and maturation in American cranberry, Vaccinium macrocarpon Ait. Plant Sci 2004;167:1043-54
129. Bodet C, Chandad F, Grenier D. Anti-inflammatory activity of a high-molecular weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res 2006;85: 235-9
130. Kim MJ, Ohn J, Kim JH, et al. Effects of freeze-dried cranberry powder on serum lipids and inflammatory markers in lipopolysaccharide treated rats fed an atherogenic diet. Nutr Res Pract 2011;5: 404-11
131. Milbury PE, Vita JA, Blumberg JB. Anthocyanins are bioavailable in humans following an acute dose of cranberry juice. J Nutr 2010;140:1099-104
132. Ohnishi R, Ito H, Kasajima N, et al. Urinary excretion of anthocyanins in humans after cranberry juice ingestion. Biosci Biotechnol Biochem 2006;70:1681-7
133. Xiao X, Kim J, Sun Q, et al. Preventive effects of cranberry products on experimental colitis induced by dextran sulphate sodium in mice. Food Chem 2015;167:438-46
134. Xia EQ, Deng GF, Guo YJ, et al. Biological activities of polyphenols from Grapes. Int J Mol Sci 2010;11:622-46
135. Dani C, Oliboni LS, Vanderlinde R, et al. Phenolic content and antioxidant activities of white and purple juices manufactured with organically-or conventionally-produced grapes. Food Chem Toxicol 2007;45: 2574-80
136. Corrales M, Garcá AF, Butz P, et al. Extraction of anthocyanins from grape skins assisted by high hydrostatic pressure. J Food Eng 2009;90:415-21
137. Cavallini L, Bindoli A, Siliprandi N. Comparative evaluation of antiperoxidative action of flavonoids. Pharmacol Res Commun 1978;10:133-6
138. Cook NC, Samman S. Flavonoidschemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem 1996;7:66-76
139. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-56
140. Park YK, Park E, Kim JS, et al. Daily grape juice consumption reduces oxidative DNA damage and plasma free radical levels in healthy Koreans. Mutat Res 2003;529: 77-86
141. Rhodes PL, Mitchell JW, Wilson MW, et al. Antilisterial activity of grape juice and grape extracts derived from Vitis vinifera variety Ribier. Int J Food Microbiol 2006;107:281-6
142. Frank T, Netzel M, Strass G, et al. Bioavailability of anthocyanidin-3-glucosides following consumption of red wine and red grape juice. Can J Physiol Pharmacol 2003;81:423-35
143. Bitsch R, Netzel M, Frank T, et al. Bioavailability and Biokinetics of Anthocyanins From Red Grape Juice and Red Wine. J Biomed Biotechnol 2004;2004:293-8
144. Bub A, Watzl B, Heeb D, et al. Malvidin-3-glucoside bioavailability in humans after ingestion of red wine, dealcoholized red wine and red grape juice. Eur J Nutr 2001;40:113-20
145. Marchi P, Paiotti APR, Neto RA, et al. Concentrated grape juice (G8000-) reduces immunoexpression of iNOS, TNF-alpha, COX-2 and DNA damage on 2, 4, 6-trinitrobenzene sulfonic acid-induced-colitis. Environ Toxicol Pharmacol 2014;37:819-27
146. Tian Q, Giusti MM, Stoner GD, et al. Characterization of a new anthocyanin in black raspberries (Rubus occidentalis) by liquid chromatography electrospray ionization tandem mass spectrometry. Food Chem 2006;94:465-8
147. Hager A, Howard LR, Prior RL, et al. Processing and storage effects on monomeric anthocyanins, percent polymeric color, and antioxidant capacity of processed black raspberry products. J Food Sci 2008;73:134-40
148. Jeong JH, Jung H, Lee SR, et al. Antioxidant, anti-proliferative and anti-inflammatory activities of the extracts from black raspberry fruits and wine. Food Chem 2010;123:338-44
149. Seeram NP, Adams LS, Zhang Y, et al. Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulated apoptosis of human cancer cells in vitro. J Agric Food Chem 2006;54:9329-39
150. Jung JW, Son MY, Jung SW, et al. Antioxidant properties of Korean black raspberry wines and their apoptotic effects on cancer cells. J Sci Food Agric 2009;89: 970-7
151. Wu X, Pittman HE 3rd, Prior RL. Fate of anthocyanins and antioxidant capacity in contents of the gastrointestinal tract of weanling pigs following black raspberry consumption. J Agric Food Chem 2006;54: 583-9
152. He J, Wallace TC, Keatley KE, et al. Stability of black raspberry anthocyanins in the digestive tract lumen and transport efficiency into gastric and small intestinal tissues in the rat. J Agric Food Chem 2009;57:3141-8
153. McDougall GJ, Dobson P, Smith P, et al. Assessing potential bioavailability of raspberry anthocyanins using an in vitro digestion system. J Agric Food Chem 2005;53:5896-904
154. González-Barrio R, Borges G, Mullen W, et al. Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy. J Agric Food Chem 2010;58:3933-9
155. Wang LS, Kuo CT, Stoner K, et al. Dietary black raspberries modulate DNA methylation in dextran sodium sulfate (DSS)-induced ulcerative colitis. Carcinogenesis 2013;34:2842-50
156. Montrose DC, Horelik NA, Madigan JP, et al. Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis. Carcinogenesis 2011;32: 343-50
157. Akbulut M, Calisir S, Marakoglu T, et al. Some physico-mechanical and nutritional properties of barberry (berberis vulgaris L.) fruits. J Food Process Engi 2007;32: 497-511
158. Sharifi A, Tavakolipour H, Maskooki A, et al. Evaluation of Barberry colour extraction. 18th National Congress on Food Technology; Mashhad, I. R. Iran (In Farsi); 2008. p. 268
159. Motalleb G, Hanachi P, Kua SH, et al. Evaluation of phenolic content and total antioxidant activity in Berberis vulgaris fruit extract. J Biological 2005;5:648-53
160. Svarcova I, Heinrich J, Valentova K. Berry fruits as a source of biologically active compounds: the case of Lonicera caerulea. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007;151:163-74
161. Minaiyan M, Ghannadi A, Mahzouni P, et al. Comparative Study of Berberis vulgaris Fruit Extract and Berberine Chloride Effects on Acetic Acid-Induced Colitis in Rats. Iran J Pharm Res 2011;10: 97-104
162. Saito T, Honma D, Tagashira M, et al. Anthocyanins from new red leaf tea "Sunrouge". J Agric Food Chem 2011;59: 4779-82
163. Akiyama S, Nesumi A, Maeda-Yamamoto M, et al. Effects of anthocyanin-rich tea "Sunrouge" on dextran sodium sulfate-induced colitis in mice. BioFactors 2012;38:226-33
164. Zhang C, Monk JM, Lu JT, et al. Cooked navy and black bean diets improve biomarkers of colon health and reduce inflammation during colitis. Br J Nutr 2014;111:1549-63
165. Faria A, Fernandes I, Norberto S, et al. Interplay between anthocyanins and gut microbiota. J Agric Food Chem 2014;62: 6898-902
166. Farzaei MH, Rahimi R, Abdollahi M. The role of dietary polyphenols in the management of inflammatory bowel disease. Curr Pharm Biotechnol 2014; In press